1. Mendiburu-Eliçabe, Marina, García-Sancha, Natalia, Corchado-Cobos, Roberto, Castillo-Lluva, Sonia, Pérez-Losada, Jesús. . NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence. In Clinical and translational medicine, 14, e1554. doi:10.1002/ctm2.1554. https://pubmed.ncbi.nlm.nih.gov/38344872/
2. Li, Chao, Meng, Jun, Zhang, Tongtong. 2022. NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma. In Scientific reports, 12, 9578. doi:10.1038/s41598-022-12862-6. https://pubmed.ncbi.nlm.nih.gov/35688915/
3. Li, Bo, Xiao, Qian, Shan, Liping, Song, Yongsheng. 2022. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. In Cell cycle (Georgetown, Tex.), 21, 427-438. doi:10.1080/15384101.2021.2021050. https://pubmed.ncbi.nlm.nih.gov/34974790/
4. Wang, Yan, Li, Jun-Qiang, Yang, Zhi-Liang, Li, Zi-Yue, Qin, Long. 2021. NCAPH regulates gastric cancer progression through DNA damage response. In Neoplasma, 69, 283-291. doi:10.4149/neo_2021_210607N761. https://pubmed.ncbi.nlm.nih.gov/34962823/
5. Wang, Meng, Qiao, Xiaowen, Cooper, Tamara, Zhang, Ranran, Wang, Xiao. 2020. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. In Cell death & disease, 11, 1049. doi:10.1038/s41419-020-03244-9. https://pubmed.ncbi.nlm.nih.gov/33311486/
6. Lei, Yuehua, Wang, Dengchao, Chen, Wenxing, Tian, Xiaojun, Wei, Jian. 2023. FOXM1/NCAPH activates glycolysis to promote colon adenocarcinoma stemness and 5-FU resistance. In Anti-cancer drugs, 34, 929-938. doi:10.1097/CAD.0000000000001526. https://pubmed.ncbi.nlm.nih.gov/37260271/